Health Archive » October, 2019

Health - October, 2019

392 articles

• Opioid MDL Attys Poised To Debate Next Bellwether Trials
• Domestic Worker Bill Of Rights Advances In Philadelphia
• Boston Scientific Says Sanctions Stem From 'Fictional Story'
• Vague Insurance Test May Spur Erratic Green Card Decisions
• Michigan Vape Co. Drops Federal Suit After Ban Paused
• Trans Bias Row Goes On As Justices Mull LGBTQ Protections
• Vanda Pharma Wants Del. Derivative Suit Moved To NY
• Blue Cross Parent Sued Over Strict Mental Health Care Vetting
• 6th Circ. Revives Benefits Bid From Nurse With Leukemia
• Medical E-Records Provider's $29M IP Claims Handed To Jury
• New Regulatory Concerns For Behavioral Telehealth Providers
• 5 Trends Influencing RFPs For Law Firms
• Appeals Court Won't Revive Indian Doctor's $20M Bias Suit
• 2nd Circ. Halves $19.4M Forfeiture In Valeant Kickback Case
• Mass. Judge Refuses To Halt Tweaked Statewide Vape Ban
• Alsup Slams HHS Rule Shielding Anti-Abortion Health Workers
• Atty Had Good Reason For No-Show At Trial, NY Court Says
• Rebuffed By Justices, Hospital Workers Turn To State Courts
• Health Care Ad Agency Settles DOJ Fraud Claims For $70M
• Trump Hit With 1st Suit Over Ban On Uninsured Immigrants
• Real Estate Rumors: Citrin Cooperman, Oak Street, L+M
• DaVita Healthcare Beats Ex-Nurse's Bias Suit In 9th Circ.
• Tax Court Decision May Open Up New Challenges To 280E
• Team Health Can't Completely Dodge Doctor Bonuses Suit
• Vivo Capital Collects $1.43B For Health Care Investment Fund
• 2nd Circ. Mulls Legality Of MD's 'Icky' Drug Stock Trades
• Baker McKenzie, Paul Hastings Steer $530M Daelim Latex Buy
• MDLs Are Redefining The US Legal Landscape
• Calif. Labor Law For Cannabis Cos. May Be Unconstitutional 
• Invisalign Maker Exits Shareholder Suit Over Expiring Patents
• 2nd Circ. Upholds Ex-Katten Atty's Shkreli Fraud Conviction
• Ill. Patient Needn't Produce Records In Botched Surgery Suit
• Missouri Medical Marijuana Group Asks State For Vaping Regs
• ​​​​​​​Allergan's $750M Deal Among Pharma's Top Antitrust Payouts
• 4th Circ. Won't Let SC Yank Planned Parenthood's Funding
• New Mass. Vape Ban 'A Mockery' Of Court Orders, Shops Say
• Judge Won't Approve Dignity Health Deal To End ERISA Suit
• Mallinckrodt Defends Price Hike As Necessary To Save Drug
• With No Product ID, Ethicon Escapes Pelvic Mesh Suit
• 'Near-Total Ban On Abortion' Blocked By Ala. Judge
• On-Sale Bar Ruling Invites 'Exploitation,' Justices Told
• Why I Became A Lawyer: Being There For Families In Trouble
• The Funding Outlook For Soon-To-Expire Health Programs
• Protecting Against Corruption In State Cannabis Licensing
• Pepper Hamilton Guides Medical Device Maker's $60M IPO
• Hospital System Inks $20M Deal To End False Claims Act Suit
• J&J Discloses Grand Jury Subpoena For Opioid Distributions
• Utah Judge Puts Emergency Flavored Vape Rule On Hold
• Unions Didn't Flout Law In Nursing Home Dispute, Judge Says
• Calif. Cannabis Patient Takes Edible Eviction Case To 9th Circ.
• Fla. Court Sends UHC Cancer Coverage Suit To Mass.
• FTC Rips Gilead's 'Erroneous' Argument In HIV Drug Rumble
• Insys Doc's Sentence Called A Warning To Medical Community
• 3rd Circ. Revives Merck's Arbitration Bid In Vaccine Suit
• House OKs Age-Check Mandate For Online E-Cigarette Sales
• PTAB Sinks Challenges To Disinfectant Lighting Patents
• Best Practices For US-Canada Virtual Mass Tort Teams
• Chinese Distributor Can't Pause US Co.'s Trade Secrets Suit
• Romanucci Atty Will Lead Sterigenics Emissions Suits In Ill.
• Woman Wants New Trial In Sanofi Chemo Drug Bellwether
• Law360's Tort Report: Personal Injury & Med Mal News In Brief
• Quest Settlement Of Data Breach Suit Gets Waved Through
• In Lung Injuries Probe, Officials Are Looking Beyond THC
• PBM Group Says ERISA Trumps New Okla. Insurance Law
• VA Proposes Tweaks To Third-Party Care Payment Rules
• Pharmacy Claims Online Rx Co. Strangled Market
• Novartis Sues Indian Generic Cos. Over Heart Failure Drug IP
• Lactation Claims Too Varied For Class, UnitedHealth Says
• Philly Hospital Operator Asks For More Time On Ch. 11 Plan
• USCIS Limits Eligibility For Immigration Petition Fee Waivers
• Grit Real Estate Drops $104M On 7 Africa Properties
• Taxation With Representation: Weil, Gibson, Blake, Baker
• NFL Urges 9th Circ. To End Ex-Players' Painkiller Suit
• Counseling Cannabis Cos. Requires A Holistic Approach
• Concussion Testing Co. Calls Out Competitor In False Ad Suit
• Patient Assistance Groups Settle Kickback Claims For $6M  
• Texas Court Rules Hospital Must Face Patient Death Suit
• RI Flavored Vape Ban Latest To Face Court Challenge
• Associates Found Guilty In Doc's Major Oxy-Pushing Scheme
• FDA Yanks Homeopathy Compliance Policy As Inadequate
• Ex-Wyndham Worker Not Covered For 'Experimental' Surgery
• RJR Cleared Of Liability In Florida Smoker's Death
• Canadian Co. Can't Nix 'Rogue' Arbitrator's $1.8M Award
• 'Inhumane' DC Hospital Lacks Running Water, Patients Say
• Clinic Doc Not Liable For Fatal Prescription, 3rd Circ. Says
• Fed. Court Tosses Remainder Of Health Plan Marketing Suit
• GSK Loses Bid To End 53 Zofran Birth Defects Cases
• Examine Diversity Jurisdiction By Drilling Into Citizenship
• Ex-Rite Aid Exec Gets 2 Years For Role In Kickback Scheme
• Device Maker, Execs To Pay $6M To End Feds' FCA Claims
• Mich. Order Muddles No-Fault Reform For Auto Insurers
• Loestrin Buyers' $1M Lupin Deal Gets Initial Approval
• Holland & Hart Leads Weave's $70M Funding
• Hong Kong Childhood Can't Diminish J&J Talc Risk, Jury Told
• Okla. Judge Temporarily Blocks Reversible Abortion Info Law
• Birth Defect Report Trimmed By Judge In Zofran MDL
• Trump's Insurance Policy Hurts Poor Immigrants, Sens. Say
• Ill. Court Upholds Doc's Trial Win In Botched Leg Surgery Suit
• Trans Prof's Gender Surgery Suit Won't Wait For High Court
• O'Melveny Launches State Regulatory Defense Group
• IRS Bar On Pot Biz Deductions Constitutional, Tax Court Says
• Surgeon General Warns Senate About Perils Of Legalizing Pot
• 6th Circ. Won't Revive Ex-Salvation Army Director's Bias Suit
• Feds Owe ACA Insurers $1.6B, Claims Court Rules
• State Dept. Delays Use Of 'Public Charge' Form At Consulates
• 3rd Circ. Won't Revive Bid To Halt Abortion Protest Buffer Law
• Cigna Beats Suit Over Covering Special Liposuction Treatment
• Ky. AG Announces $40M In Settlements With Bayer, Reckitt
• Gov't Wants Philly Hospital Program's Ch. 11 Sale Reversed
• Is There A Legal Standard Of Care For Legionnaires' Disease?
• Where Law Firm Partners Go When Changing Jobs
• Congress Chose To Block $12B In ACA Funds, Justices Told
• FDA Struggles To Foster An Affordable Biosimilar Insulin
• EEOC Suit Tossed For Not Showing Anxious Worker Protected
• FDA To Require Warning Labels On Breast Implants
• Asbestos Slipped Into J&J's Talc Supply, LA Jury Hears
• Feds Slam Pharma CEO's Bid To Nix Opioid Trafficking Charge
• 9th Circ. Affirms Block Of Trump Admin.'s Birth Control Rules
• VA Deal Not Just For Veteran Cos., Court Says, Sinking Protest
• Nursing Home Co. Can't Dodge Age Bias, FMLA Claims
• Momenta, Sandoz Can't Pause Blood-Clot Drug Antitrust Suit
• Chicago Insurance Exec Sentenced To 4 Years For $13M Fraud
• California's Pot Regulation Maze Keeps Businesses On Edge
• Trans Librarian Says Surgery Suit Can't Wait For High Court
• Tivity Board Slips Derivative Suit Over UnitedHealthcare Deal
• 3 Ways To Leverage Vulnerability For Lawyer Well-Being
• Hyland's Must Face Revived Suit Over Infant's Death
• UnitedHealth Drops Push For High Court Input On Plan Offsets
• FDA, FTC Issue Warning On Claims CBD Can Treat Diseases
• The FDA Regulatory Landscape For Tobacco And Cannabis
• RI Governor Sues Lawmakers Over Control Of Cannabis Regs
• Pfizer, Sanofi Sued Over Possible Zantac-Cancer Link
• E-Records IP Claims A Ploy To Stifle Competition, Jury Told
• $48B Opioid Deal Outcry May Presage Plaintiff Infighting
• Insurance Customers To Try Again On Sutter Damages Class
• FTC Probes Clearances For Local Health Mergers
• DOJ Moves To Collect DNA From Detained Immigrants
• Mental Health Center Not Covered In Bias Suit, 2nd Circ. Told
• Oregon Pot Shop Will Give Up License Over Same-Day Sales
• State AGs Reach $48B Proposed Deal To End Opioid Cases
• 'Public Charge' Rule On Hold, But Employers Should Prepare
• CMS Can't Shake Hospitals' Win In Reimbursement Battle
• Medical Pot Co. Worker Sues For Retaliation, Discrimination
• 2nd Circ. Revives Part Of EmblemHealth Execs' Benefits Suit
• Novartis Hit With Retaliation Suit Over Kickback Scheme
• Opioid Trial Halted By Drug Cos.' 11th Hour $260M Deal
• Humana Slaps Generic-Drug Makers With New Price-Fix Suit
• Court Asks Fla. Justices To Review Med Mal Death Law
• Fight Over Utah's Medical Pot Effort Bumped To State Court
• DC Circ. Tosses Medical Pot Researcher's Fight With DEA
• La. Insurer Sues Pharma Cos. Over Opioid Crisis
• Quiet Abortion 'Counseling' OK In Buffer Zone, 3rd Circ. Says
• AIG Wants Out Of Covering Clinic's $9M Abuse Settlement
• Judge Sees Dwindling Evidence Anchoring HHS Abortion Rule
• 11 Firms To Guide 8 IPOs Seeking $826M
• Shumaker Loop Beats DQ Bid From Bankrupt Cancer Center
• Ill. City Ran To Court In Discovery Row, Express Scripts Says
• Philly Workers Not Exempt From OT Under FLSA, Judge Says
• New Data Shows BigLaw's True Profitability
• PTAB Told To Weigh Invalid Claim Language In Ethicon Patent
• Taxation With Representation: Weil, Skadden, Kirkland
• Health Hires: White & Case, Epstein Becker
• How 280E Became The Pot Industry's Boogeyman
• In Most Court Battles, States Win And Trump Loses
• NECC Pharmacists Lose Bid For New Trial In Meningitis Case
• Justices' LGBT Bias Ruling May Have Big Impact On Benefits
• Zoning Compliance Tips For NJ Medical Marijuana Facilities
• Santa Clara Firefighters Reach $2.7M Deal To End OT Suit
• J&J Recalls Asbestos-Tainted Baby Powder Flagged By FDA
• What To Watch As Opioid MDL Nears Moment Of Truth
• Oregon's Flavored Vape Ban Put On Hold Amid Legal Fights
• Ex-Okla. Gov't Atty Admits Fake Death Threats Over Pot Laws
• Under Siege, Juul Pulls Most Flavors From US Market
• Insys Exec Trial Fair Despite Alleged Weil Conflict, Judge Says
• Boston Scientific Sanctioned For 'Shenanigans' In FCA Suit
• Mylan Case Shows SEC Stance On Disclosing Investigations
• AmerisourceBergen Brass Sued In Del. Over Drug Scheme
• SmileDirect Accuses Calif. Dental Board Of Harassment
• Calif. Doctor Guilty In $12M Medicare Fraud Scheme
• HHS Anti-Kickback Proposal Features 3 Key Safe Harbors
• Allina Health Strikes $2.4M Deal To End ERISA Class Action
• J&J To Pay States $117M To Quell Pelvic Mesh Suits
• RiverGlade Grabs $325M For Debut PE Health Care Fund
• Texas Judge Tosses ACA's Transgender, Abortion Bias Rule
• 8 Best Practices For Cannabis Transaction Due Diligence
• Calif. Woman Gets Surgery Clinic Injury Suit Reinstated
• Feds Pay $5M To End Ky. Baby Birth Injury Suit
• FTC Judge Finds 2 Dental Suppliers Violated Antitrust Law
• NY Doc's Improper 'Habit' Testimony Sparks Med Mal Retrial
• Vape Flavor Ban May Create Black Market, Lawmakers Told
• Could UPMC Have Warned Of Violent Patient, Pa. Justices Ask
• Why Trump's Orders On Agency Guidance Are Significant
• Mass. Vaping Illnesses Mount As Legal Fight Over Ban Swirls
• Drug Cos. Float Deals Worth $50B To End Opioid Cases
• Shkreli Asks Justices To School 2nd Circ. On Securities Fraud
• Health Care Co. Can't Nix Pump-And-Dump Suit, Judge Says
• Philips Trying To 'Bury History' In Tracker IP Suit, Garmin Says
• Insys Judge Unsure If Execs' Bribes Equal Drug Dealing
• Thomson Geer To Steer Australian Cannabis Co.'s $13.5M IPO
• Fla. High Court To Review Ruling Against Medical Pot Regs
• Rising Star: Quinn Emanuel's Meghan McCaffrey
• Sutter Health, Calif. AG Near Antitrust Deal On Eve Of Trial
• Fried Frank Assists As Permira Clinches €11B Buyout Fund
• Ala. Clinic Hit With $9M Verdict In Patient Death Suit
• Pa. Jury Awards $4.7M In Spine Infection Misdiagnosis Trial
• Calif. Pot Cos. Must Sign 'Labor Peace' Deals After 20th Hire
• Pa. Justices Ask If Judge Missed Chance To Weigh Juror Bias
• True Health Set To Begin Soliciting Votes On Ch. 11 Plan
• AmerisourceBergen Fights To Shield Opioid Docs At Chancery
• Real Estate Rumors: GL, First Industrial, Healthcare Realty
• Locke Lord Says Failed Health Plan Suit Dead On Arrival
• Michigan Vape Ban Halted After Claims Of Business Harm
• Tenet Says Philly Hospital Owner Needs To Pay Up In Ch. 11
• AbbVie Says Humira's Many Patents Is No Antitrust Violation
• 'Novel' Disclosure Issue Not Ready For Del. Supreme Court
• How AI Is Shaping FDA Medical Device Regulation
• CMS Stark Law Proposal Goes Beyond Value-Based Care
• Ex-Katten Atty's Jury Gripe Falls Flat With 2nd Circ. Judge
• Grading The Presidential Candidates On Cannabis Policy
• Veritas Capital Taps Kirkland For $6.5B PE Fund
• High Court Won't Hear $2.7M Fees Appeal In BioScrip Deal
• Willkie Steers $910M Sale Of Crisis Training Co.
• Courts Keep Rejecting Litigation Funding Discovery Campaign
• Woman's Brain Damage Came During Surgery, Doc Testifies
• Teva, Mylan, Other Generic Makers Hit With Price-Fixing Suit
• Purdue Opioid Suits Get One-Month Pause, For Now
• 6th Circ. Keeps Block On Ohio Down Syndrome Abortion Ban
• J&J Wins Second Asbestos-In-Talc Trial In A Week
• Mass. Gov. Fights To Keep Vape Ban Fight In Fed. Court
• Claims Court Says Task Order Adjustments Can't Be Protested
• How Emotionally Intelligent AI Could Assist With E-Discovery
• Chicago's Ex-Chief Judge Turns To 'Unfinished Business'
• FDA Focus: What BakerHostetler's Practice Chair Is Watching
• Trump's Medicaid Work Requirements Questioned By DC Circ.
• 2nd Circ. Orders Damages Redo In Health Plan Funding Row
• Job Wrongly Rescinded Over Medical Marijuana, Pa. Man Says
• Taxation With Representation: Latham, Covington, Vinson
• Pa. Can Trim Workers' Comp. By Degree Of Injury, Panel Says
• Injury Atty Indicted, Accused Of Trying To Hide $1M From IRS
• Tour Buses 'Thumbed Nose' At Health Care Law, SF Says
• 5th Circ. Won't Revisit Ruling Nixing Tenn. Benefits Law
• 9th Circ. Frees 'Last Resort' Insurer From Medicare Payments
• House Leader To Subpoena USCIS, ICE Over Deferred Action
• What Do Trump's Orders Mean For Agency Guidance?
• Tiversa Can't Keep Up With LabMD Defamation Doc Demands
• FCA Decision Tracker: Continued Interpretations Of Escobar
• Jury Bias Claim Can't Undo $7.6M Nursing Home Death Award
• Dental Startup Settles With Last Distributor In Boycott Suit
• Court Told Settlement Is The Best Result For Purdue Ch. 11
• Walgreens Can't Sink Pharmacist's Age, Disability Bias Case
• UBiome's Ch. 7 Case Conversion Approved In Del.
• UnitedHealthcare Can't Dodge Mental Health Treatment Suit
• $11M ERISA Deal Over Hospital Pension Plan Wins OK
• Mich. Pot Testing Lab Fined $100K Over Flawed Methods
• Washington State Implements Vape Ban After Executive Order
• Suit Claiming NFL Cheated Illinois Clinic Moved To Texas
• Mo. Woman Gets 57 Months For Medicaid, Tax Fraud Scheme
• J&J Beats Class Action Over Opioid Health Insurance Costs
• Preventable Risks Your Law Firm May Be Overlooking
• Ohio Trial In Opioid MDL Will Go Forward, 6th Circ. Says
• 3 Firms Guide Medical Billing Co. Deal Worth Up To $300M
• Gerber Sales Rep Tells Jury Co. Fired Her After Pregnancy
• Genetic Testing Co., 3 Others To Pay $42.6M Over FCA Claims
• Manatt Nabs Former McDermott Litigation Pro In LA
• What Your Practice Needs To Know About Telehealth
• Conn. Fits Teva Stock-Drop Suit Better Than Pa., Judge Says
• Bad Juror Claim Can't Undo Pa. Doc's Med Mal Trial Win
• Chinese Distributor Can't Shake Trade Secrets Suit
• HHS Unveils Plan For Kickback, Stark Law Changes
• J&J Cleared By Calif. Jury In Talc Cancer Retrial
• Salix Pharma Beats Ex-Worker's FCA Retaliation Suit
• Cannabis Investor Must Arbitrate Equity Fight Over $1.35B IPO
• Fresenius To Pay $5M To Resolve Mass. Medicare Fraud
• Rival's Plagiarism Claim Is Bogus, Nursing Course Co. Says
• Cannabis-Focused Blank Check Co. Merida Files $100M IPO
• Wrongful Death Appeal Fails On Scant Briefing, Ill. Court Says
• 4 Trends To Watch In Toxic Tort Litigation
• Doc Who Led Major Oxy-Pushing Scheme Working With Feds
• Rising Star: Manatt's Randi Seigel
• 6 Ethics Tips For Attorneys Making Lateral Transfers
• DOL Says Investment Manager Failed To Diversify 401(k) Plan
• Dickinson Wright Adds Cannabis Pro In Ohio
• Phelps Dunbar Nabs Baker Donelson Health Care Team
• Ex-Biomet Employee Can't Sue Over FCPA Firing: 7th Circ.
• Questions Swirl Around Opioid MDL Bellwether Trial
• Purdue's Sackler Family Loses Bid To Toss Mass. Opioid Suit
• Purdue Agrees To Put Off Consideration Of Ch. 11 Bonuses
• Levi & Korsinsky Picked To Lead Corcept Stock Drop Suit
• Ga. Jury Deadlocks In Latest J&J Talc Cancer Trial
• Texas Justices Asked To Renew Suit Against Univ. Hospital
• 2 Overlooked Areas Of DHS' New 'Public Charge' Rule
• Ill. Hospital's Trial Win Affirmed In Post-Surgery Death Suit
• Rehab Workers Reach Deal In Health Benefits Dispute
• NY's Most Prolific Oxy Doc Set To Plead Guilty, Feds Say
• Attys Denied Fee Set-Aside In Generics Antitrust Case
• Insys Seeks Extension Of Ch. 11 Plan Exclusivity Period
• Third Insurer Pulled Into Pa. Grocer's Opioid Defense Suit
• Junk Faxes? More Like 'Good Customer Service,' Judge Says
• Cannabis Cos. MedMen And PharmaCann Cancel $682M Deal
• Rising Star: Hooper Lundy's Eric Chan
• DOJ's Qui Tam Approach Seems To Be Shifting
• Calif. Becomes 1st State To Target 'Pay-For-Delay' Drug Deals
• Merck Fires Back At Pfizer's Bid To Nix Trade Secret Suit
• One Equity Partners Clinches 7th PE Fund With $1.75B In Tow
• Gender Surgery Suit Should Wait For High Court, Judge Says
• Choate Hall & Stewart Guides Sverica's $450M Fund Closing
• J&J Talc Trial Closes With Each Side Blasting Other's Experts
• Ga. Justices Call Off New Trial In Bad-Diagnosis Suit
• Trump Admin. Asks High Court To End ACA Birth Control Saga
• Justices Won't Hear KPMG's Appeal In Pension Audit Row
• Medical Co. Beats Claims Kid's Health Costs Got Dad Fired
• Ky. Docs Must Face Suit Over Clinical-Trial Patient's Cancer
• Feds Want To Pull Bond For Owner Of Gene Testing Lab
• Justices Won't Hear Pharma Case Over FCA's Public Info Bar
• Justices Pass On BCBS' Challenge To $9.5M Encompass Win
• Juror Flub Axes Doc's Med Mal Trial Win, Ind. Court Says
• Monsanto's Final Roundup Trial Of 2019 Called Off Indefinitely
• Employers Look To NJ High Court For Clarity On Medical Pot
• Rising Star: Hogan Lovells' Margaux Hall
• High Court Won't Review Hospital's Win In Whistleblower Suit
• UPMC Says 60K Employees Lack Standing In Data Breach Suit
• Bid To Boot Opioid Judge Raises Questions On Judicial Roles
• High Court Sends TCPA Junk Fax Dispute Back To 6th Circ.
• Email Notice Lessons From 7th Circ. Debt Collection Ruling
• Neb. Justices Uphold $800K Win For Missed Foot Diagnosis
• Ruling Endangers Philly Hospital Program's Ch. 11 Sale
• Abortion Not On Trial In Planned Parenthood Suit, Judge Says
• Trump Blocks Uninsured Immigrants From Entering US
• Mortality Table Ruling Needs Redo, Cigna Workers Say
• When The Jury's Vote Isn't The End: Recent Verdict Reversals
• 3rd. Circ. Won't Revive WR Grace, Hospital Asbestos Fight
• Retailers Win Fight Over How To Carve Loestrin Antitrust Trial
• 25 AGs Say Purdue, Sackler Suits Should Proceed In Ch. 11
• Dental Board Members Look To Extract Immunity At 11th Circ.
• Cooley Says Theranos Founder Holmes Not Paying Legal Bills
• 5 Health Care Battles To Watch In Supreme Court's New Term
• FDA Chief Warns Against Use Of THC Vapes Amid Crisis
• DC Targeted Worker For Using Medical Pot, ACLU Suit Says
• AdvoCare Deal Puts FTC's 13(b) Authority In Spotlight
• Chancery Was Correct To Toss Dilution Suit, Del. Justices Say
• Feds, States Won't Join Allergan Glaucoma Drug FCA Suit
• Battles Still Rage Over Calif. Data, Worker Classification Laws
• Supreme Court Will Revisit Abortion Rights Battleground
• NY, Calif., 24 Other States Fight Purdue's $38M Bonus Plan
• Planned Parenthood Tells Jurors Of Fight Over Secret Videos
• Insurer Not On Hook For $5M In Air Ambulance Bills
• Trump Orders HHS To Bolster Medicare Advantage
• Qatar Foundation Validly Nixed $2.3B Deal, Court Says
• NY Appeals Court Temporarily Blocks Flavored Vape Ban
• CDC, FDA Ramp Up Vape Alarms As Lung Injury Cases Top 1K
• Momenta, Sandoz Try To Pause Blood-Clot Drug Antitrust Suit
• ERISA Ruling Signals Change In 5th Circ. Preemption Analysis
• Hospital Chain Can Fight FCA Atty Fees, Judge Rules
• 'Boilerplate' Mednax Stock Drop Suit Dismissed
• FTC Seeks E-Cigarette Cos.' Data On Advertising, Sales
• 4 Plead Not Guilty To $99M Health Care Fraud In NJ
• Consider The Power Of Tactical Empathy
• BCBS Minnesota Beats Texas Hospital's Underpayment Suit
• SmileDirectClub Hit With Investor Suit Over $1.3B IPO
• Bankrupt Philly Hospitals Seek Service Cutoff Halt For Appeal
• Tardy CPR Left Woman In Surgery Brain Damaged, Jury Told
• Trump 'Public Charge' Rule Imperils Public Health, Judge Told
• Trans Ga. Cop Sues County Over Denial Of Health Benefits
• Ex-Theranos CEO Says Feds' Discovery Delay Is 'Deja Vu'
• 4 Key Moments From J&J's Mesh Marketing Battle With Calif.
• Pa. Hospital, Doc Escape Infant Death Suit
• Nuns Urge Supreme Court Action On ACA Birth Control Rule
• AdvoCare Pays $150M To Settle FTC Pyramid Scheme Claims
• FDA Warns Of Security Flaws Lurking Within Medical Devices
• Gov't Says No Need To Revisit FCA Dismissal Authority
• 3rd Circ. Doubts Merck's Arbitration Bid In Vaccine Suit
• Opioid Distributor CEO Seeks To Toss Drug Trafficking Charge
• JPML Sends Juul Marketing Suits To Calif.
• The Problem — And Opportunity — Of Implicit Bias In The Bar
• Wisconsin Trailing In Midwest's Race To Legalize Cannabis
• Georgia's 'Fetal Heartbeat' Abortion Law Hits Roadblock
• UBiome Seeks Liquidation As Creditors Balk On DIP Loan
• J&J Inks $20.4M Deal Just Ahead Of Opioid Bellwether
• Opioid MDL Judge Rips Ohio AG's Late Bellwether Attack
• USC Insurer Fights Arbitration Over $215M Sex Abuse Deal
• Worker Not Libeled By Unfit-For-Duty Report, 1st Circ. Rules
• $14.2M Verdict Affirmed For Patient With Rare Bowel Disease
• Walgreens Ditches FCA Suit Over Prescription Autorefills
• Analogic Exits Investor Challenge To $1.1B Altaris Tie-Up
• Cannabis Industry Lobby Says FDA Should Regulate Legal Pot
• Pa. Pharmacy Still Can't Shed Horizon's $10M Fraud Suit
• Wash. Service Workers Union Inks $3.3M Union Fees Deal
• Judging A Book: Thapar Reviews Gorsuch's 'A Republic'
• EPA Forced To Face Flint Residents' $4.5B Water Crisis Claims
• DEA Slow To Act In Opioid Crisis, Inspector General Says
• 2 Trends In DOJ Health Care Enforcement
• Drug Cos. Push 6th Circ. To Disqualify Opioid MDL Judge